Carrier materials for spinal fusion

Spine Journal

Volumn 5, Issue 6 SUPPL., 2005, Pages S224-S230

  Kwon, Brian ^a   Jenis, Louis G ^a  

^a NEW ENGLAND BAPTIST HOSPITAL   (United States)

Author keywords

BMP; Bone graft substitutes; Ceramics; DBM; Spinal fusion

Indexed keywords

BIOMATERIAL; BONE MORPHOGENETIC PROTEIN; CALCIUM PHOSPHATE; CALCIUM PHOSPHATE CERAMIC; CARBOXYMETHYLCELLULOSE; COLLAGEN; COPOLYMER; HYDROXYAPATITE; MACROGOL; MACROGOL 200; MACROGOL 3000; OSTEOGENIC PROTEIN 1; POLYGLYCOLIC ACID; POLYLACTIC ACID; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; RECOMBINANT GROWTH FACTOR;

BIOCOMPATIBILITY; BIODEGRADABLE IMPLANT; BONE ALLOGRAFT; BONE CONDUCTION; BONE GRAFT; BONE MATRIX; CHEMICAL COMPOSITION; CLINICAL TRIAL; DRUG DELIVERY SYSTEM; HUMAN; MEDICAL DECISION MAKING; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; PSEUDARTHROSIS; REVIEW; SPINE FUSION; STEM CELL TRANSPLANTATION; SURGEON; SURGICAL SPONGE; TREATMENT OUTCOME;

EID: 28244495581     PISSN: 15299430     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.spinee.2005.02.007     Document Type: Article

References (66)

1. H. Sandhu H. Grewal H. Parvataneni Bone grafting for spinal fusion Ortho Clin North Am 30 1999 685-698
2. T. Akamaru D. Suh S. Boden et al. Simple carrier matrix modifications can enhance delivery of recombinant human bone morphogenetic protein-2 for posterolateral spine fusion Spine 28 2003 429-434
3. S. Boden J. Kang H. Sandhu J.G. Heller Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: A prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies Spine 27 2002 2662-2673
4. S.D. Boden Evaluation of carriers of bone morphogenetic protein for spinal fusion Spine 26 2001 850-856
5. M. Geiger R. Li W. Friess Collagen sponges for bone regeneration with rhBMP-2 Adv Drug Deliv Rev 55 2003 1613-1629
6. G. Martin S. Boden L. Titus Recombinant human bone morphogenetic protein-2 overcomes the inhibitory effect of ketorolac, a nonsteroidal anti-inflammatory drug (NSAID), on posterolateral lumbar intertransverse process spine fusion Spine 24 1999 2188-2193
7. D. Suh S. Boden J. Louis-Ugbo et al. Delivery of recombinant human bone morphogenetic protein-2 using a compression-resistant matrix in posterolateral spine fusion in the rabbit and in the non-human primate Spine 27 2002 353-360
8. S.D. Boden G. Martin M. Morone et al. Posterolateral lumbar intertransverse process spine arthrodesis with recombinant human bone morphogenetic protein 2/hydroxyapatite-tricalcium phosphate after laminectomy in the nonhuman primate Spine 24 1999 1179-1185
9. E.M. Erbe J. Marx T. Clineff et al. Potential of an ultraporous beta-tricalcium phosphate synthetic cancellous bone void filler and bone marrow aspirate composite graft Eur Spine J 10 2001 s141-s146
10. J. Louis-Ugbo H. Murakami H. Kim et al. Evidence of osteoinduction by Grafton demineralized bone matrix in nonhuman primate spinal fusion Spine 29 2004 360-366
11. J.S. Thalgott J. Giuffre Z. Klezl et al. Anterior lumbar interbody fusion with titanium mesh cages, coralline hydroxyapatite, and demineralized bone matrix as part of a circumferential fusion Spine J 2 2001 63-69
12. H. Seeherman J. Wozney R. Li Bone morphogenetic protein delivery systems Spine 27 2002 s16-s23
13. J. Fischgrund S. James M. Chabot et al. Augmentation of autograft using rhBMP-2 and different carrier media in the canine spinal fusion model J Spinal Disord 10 1997 467-472
14. N. Saito T. Okada M. Horiuchi et al. Biodegradable poly-D,L-lactic acid-polyethylene glycol block copolymers as a BMP delivery system for inducing bone J Bone Joint Surg 83A 2001 s92-s98
15. M. Asselmeier R. Caspari S. Bottenfield A review of allograft processing and sterilization techniques and their role in transmission of human immunodeficiency virus Am J Sports Med 21 1993 170-175
16. D. Ehrler A. Vaccaro The use of allograft bone in lumbar spine surgery Clin Orthop Rel Res 371 2000 38-45
17. M. Niederwnager M. Urist Demineralized bone matrix supplied by bone bank for a carrier of recombinant human bone morphogenetic protein (rhBMP-2): a substitute for autogeneic bone grafts J Oral Implantol 22 1996 210-215
18. G. Martin S. Boden L. Titus et al. New formulations of demineralized bone matrix as a more effective graft alternative in experimental posterolateral lumbar spine arthrodesis Spine 24 1999 637-645
19. M.R. Urist Bone: Formation by autoinduction Science 150 1965 893-899
20. K. Takaoka M. Nakahara H. Yoshikawa et al. Ectopic bone induction on and in porous hydroxyapatite combined with collagen and bone morphogenetic protein Clin Orthop Rel Res 234 1988 250-254
21. S. Miyamoto K. Takaoka T. Okada et al. Evaluation of polylactic acid homopolymers as carriers for bone morphogenetic protein Clin Orthop Rel Res 278 1999 274-285
22. C.J. Damien D. Grob S.D. Boden J.J. Benedict Purified bovine BMP extract and collagen for spine arthrodesis: Preclinical safety and efficacy Spine 27 2002 s50-s58
23. R. Li R. Wozney Delivering on the promise of bone morphogenetic proteins Trends Biotechnol 19 2001 255-265
24. S. Winn H. Uludag J. Hollinger Carrier systems for bone morphogenic proteins Clin Orthop Rel Res 367 1999 s95-s106
25. W. Friess H. Uludag S. Foskett R. Biron C. Sargeant Characterization of absorbable collagen sponges as rhBMP-2 carriers Int J Pharm 187 1999 91-99
26. M. Alam I. Asahina K. Ohmamiuda K. Takahashi S. Yokota S. Enomoto Evaluation of ceramics composed of different hydroxyapatite to tricalcium phosphate ratios as carriers for rhBMP-2 Biomaterials 22 2001 1643-1651
27. B. Hecht J. Fischgrund H. Herkowitz L. Penman J. Toth A. Shirkoda The use of recombinant human bone morphogenetic protein 2 (rhBMP-2) to promote spinal fusion in a human primate anterior interbody fusion model Spine 24 1999 629-636
28. J.K. Burkus S. Heim M. Gornet et al. Is INFUSE bone graft superior to autograft bone? An integrated analysis of clinical trials using the LT-CAGE lumbar tapered fusion device J Spinal Disord Tech 16 2003 113-122
29. D. Bomback J. Grauer R. Lugo N. Troiano T. Patel G. Friedlander Comparison of posterolateral lumbar fusion rates of Grafton putty and OP-1 putty in an athymic rat model Spine 29 2004 1612-1617
30. J. Grauer T. Patel J. Erulkar N. Troiano M. Panjabi Evaluation of OP-1 as a graft substitute for intertransverse process lumbar fusion Spine 26 2001 127-133
31. A. Vaccaro T. Patel J. Fishgrund et al. A pilot safety and efficacy study of OP-1 putty (rhBMP-7) as an adjunct to iliac crest autograft in posterolateral lumbar fusions Eur Spine J 12 2003 495-500
32. T. Blattert G. Delling P. Dalal C. Toth H. Balling A. Weckbach Successful transpedicular lumbar interbody fusion by means of a composite of osteogenic protein-1 (rhBMP-7) and hydroxyapatite carrier: a comparison with autograft and hydroxyapatite in the sheep spine Spine 27 2002 2697-2705
33. M. Lind S. Overgaard T. Jensen et al. Effect of osteogenic protein 1 / collagen composite combined with impacted allograft around hydroxyapatite-coated titanium alloy implants is moderate J Biomed Mater Res 55 2001 89-95
34. Wheeler D. The use of non-collagen based carrier for OP-1. Paper presented at: 5th International Conference on Bone Morphogenetic Proteins; Nagoya, Japan; September 12, 2004.
35. H. Kuniyasu Y. Hirose M. Ochi et al. Bone augmentation using rhGDF-5-collagen composite Clin Oral Implants Res 14 2003 490-499
36. R. Legeros Properties of osteoconductive biomaterials: Calcium phosphates Clin Orthop Rel Res 395 2002 81-98
37. T. Jahng T. Fu B. Cunningham A. Dmitriev D. Kim Endoscopic instrumented posterolateral lumbar fusion with healos and recombinant human growth/ differentiation factor - 5 Neurosurg 54 2004 171-180
38. Y. Kuboki H. Takita D. Kobayashi et al. BMP-induced osteogenesis on the surface of hydroxyapatite with geometrically feasible and nonfeasible structures: Topology of osteogenesis J Biomed Mater Res 39 1998 190-199
39. B. Tay V. Patel D. Bradford Calcium sulfate- and calcium phosphate-based bone substitutes Ortho Clin North Am 30 1999 615-623
40. I. Ono H. Gunji F. Kaneko T. Saito Y. Kuboki Efficacy of hydroxyapatite ceramic as a carrier for recombinant human bone morphogenetic protein J Craniofac Surg 6 1995 238-244
41. P. Chistolini I. Ruspantini P. Bianco A. Corsi R. Cancedda R. Quarto Biomechanical evaluation of cell-loaded and cell-free hydroxyapatite implants for the reconstruction of segmental bone defects J Mater Sci Mater Med 10 1999 739-742
42. A.R. Vaccaro The role of the osteoconductive scaffold in synthetic bone graft Orthopedics 25 2002 s571-s576
43. W. Paul C. Shama Ceramic drug delivery: A perspective J Biomat Appl 17 2003 253-264
44. S.D. Boden D. Grob C. Damien Ne-Osteo bone growth factor for posterolateral lumbar spine fusion: Results from a nonhuman primate study and a prospective human clinical pilot study Spine 29 2004 504-514
45. D. Lee A. Tofighi M. Aiolova et al. Alpha-BSM: A biomimetic bone substitute and drug delivery vehicle Clin Orthop Rel Res 367 1999 s396-s405
46. R. Li M. Bouxsein C. Blake et al. rhBMP-2 Injected in a calcium phosphate paste (Alpha-BSM) accelerates healing in the rabbit ulnar osteotomy model J Ortho Res 21 2003 997-1004
47. S. Itoh M. Kikuchi K. Takakuda et al. The biocompatibility and osteoconductive activity of a novel hydroxyapatite/collagen composite biomaterial, and its function as a carrier of rhBMP-2 J Biomed Mater Res 54 2001 445-453
48. 125I-labeled recombinant human bone morphogenetic protein-2 by biphasic calcium phosphate or a composite sponge in a rabbit posterolateral spine arthrodesis model J Ortho Res 20 2002 1050-1059
49. A. Minamide M. Kawakami H. Hashizume R. Sakata M. Yoshida T. Tamaki Experimental study of carriers of bone morphogenetic protein used for spinal fusion J Ortho Sci 9 2004 142-151
50. M. Chapman R. Bucholz C. Cornell Treatment of acute fractures with a collagen-calcium phosphate graft material: A randomized clinical trial J Bone Joint Surg 79A 1997 495-502
51. G. Muschler S. Negami A. Hyodo et al. Evaluation of collagen ceramic composite graft materials in a spinal fusion model Clin Orthop Rel Res 328 1996 250-260
52. J. Zerwekh S. Kourosh R. Scheinberg et al. Fibrillar collagen-biphasic calcium phosphate composite as a bone graft substitute for spinal fusion J Ortho Res 10 1992 562-572
53. S. Kokubo M. Mochizuki S. Fukushima et al. Long-term stability of bone tissues induced by an osteoinductive biomaterial, recombinant human bone morphogenetic protein-2 and a biodegradable carrier Biomaterials 25 2004 1795-1803
54. R. Bucholz Nonallograft osteoconductive bone graft substitutes Clin Orthop Rel Res 395 2002 44-52
55. C. Alpaslan K. Irie K. Takahashi et al. Long-term evaluation of recombinant human bone morphogenetic protein-2 induced bone formation with a biologic and synthetic delivery system Br J Oral Maxillofac Surg 34 1996 414-418
56. Y. Kuboki M. Kikuchi H. Takita et al. Laser-perforated membranous biomaterials induced pore size-dependent bone induction when used as a new BMP carrier Connect Tissue Res 44 2003 s318-s325
57. J. Hollinger K. Leong Poly (alpha-hydroxy acids): Carriers for bone morphogenetic proteins Biomaterials 17 1996 187-194
58. H. Uladag B. Norrie N. Kousinioris T. Gao Engineering temperature-sensitive poly (N-isopropylacrylamide) polymers as carriers of therapeutic proteins Biotech Bioeng 73 2001 510-521
59. A. Vaccaro K. Singh R. Haid et al. The use of bioabsorbable implants in the spine Spine J 3 2003 227-237
60. S. David H. Gruber R. Meyer et al. Lumbar spinal fusion using recombinant human bone morphogenetic protein in the canine: A comparison of three dosgaes and two carriers Spine 24 1999 1973-1979
61. S. Miyamoto K. Takaoka T. Okada et al. Polylactic acid-polyethylene glycol block copolymer. A new biodegradable synthetic carrier for bone morphogenetic protein Clin Orthop Rel Res 294 1994 333-343
62. N. Saito K. Takaoka New synthetic biodegradable polymers as BMP carriers for bone tissue engineering Biomaterials 24 2003 2287-2293
63. J. Schrier P. Deluca Porous bone morphogenetic protein-2 microspheres: polymer binding and in vitro release AAPS PharmSciTech 2 2001 E17
64. K. Whang D. Tsai E. Nam et al. Ectopic bone formation via rhBMP-2 delivery from porous bioabsorbable polymer scaffolds J Biomed Mater Res 42 1998 491-499
65. N. Saito T. Okada H. Horiuchi et al. Local bone formation by injection of recombinant human bone morphogenic protein-2 contained in polymer carriers Bone 32 2003 381-386
66. K. Bessho D. Carnes R. Cavin J. Ong Experimental studies on bone induction using low-molecular weight poly (DL-Lactide-co-glycolide) as a carrier for recombinant human bone morphogenetic protein-2 J Biomed Mater Res 61 2002 61-65